MAP4K4 Inhibitors
Abstract
This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, for example in a method of treatment. There are also provided processes for producing compounds of the present invention and method of their use. In particular, the present invention relates to compounds of formula (I).
Collections
Subject
Kinase
Cardiovascular
Research team
Medicinal Chemistry 3
Language
eng
License start date
2019-04-18
Citation
2019